Jackie Hunter: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
KasparBot (talk | contribs)
1,549,811 edits
m I updated Jackie Hunter's Biography
Line 1: Line 1:
{{Infobox scientist
{{Infobox scientist
| name = Professor Jackie Hunter
| name = Professor Jackie Hunter
⚫
| birth_name = Ann Jacqueline Hunter<ref name="scopus">{{Scopus|id=35591418500}}</ref>
| native_name_lang =
| native_name_lang =
| image = <!--(as myimage.jpg, no 'File:')-->
| image = <!--(as myimage.jpg, no 'File:')-->
Line 7: Line 6:
| alt =
| alt =
| caption =
| caption =
⚫
| birth_name = Ann Jacqueline Hunter<ref name="scopus">{{Scopus|id=35591418500}}</ref>
| birth_date = {{Birth year and age|1956}}<ref name="rhul">{{cite web |url=http://www.rhul.ac.uk/alumni/ouralumni/notablealumni/biologicalsciences/drjackiehuntercbe(1956-).aspx |title=Royal Holloway, University of London Dr Jackie Hunter CBE (1956-) |archivedate=2013-11-11|archiveurl=http://www.webcitation.org/6L3hvFDUD}}</ref>
| birth_date = {{Birth year and age|1956}}<ref name="rhul">{{cite web |url=http://www.rhul.ac.uk/alumni/ouralumni/notablealumni/biologicalsciences/drjackiehuntercbe(1956-).aspx |title=Royal Holloway, University of London Dr Jackie Hunter CBE (1956-) |archivedate=2013-11-11|archiveurl=http://www.webcitation.org/6L3hvFDUD}}</ref>
| birth_place =
| birth_place =
| death_date = <!-- {{Death date and age|YYYY|MM|DD|YYYY|MM|DD}}
| death_date = <!-- {{Death date and age|YYYY|MM|DD|YYYY|MM|DD}} (death date then birth date) -->
(death date then birth date) -->
| death_place =
| death_place =
| resting_place =
| resting_place =
Line 21: Line 20:
| fields =
| fields =
| workplaces = {{Plainlist|
| workplaces = {{Plainlist|
* [[CEO of BenevolentBio, the bioscience division of BenevolentAI]]
* [[Biotechnology and Biological Sciences Research Council|BBSRC]]
* [[Biotechnology and Biological Sciences Research Council|BBSRC]]
* Proximagen
* Proximagen
Line 51: Line 51:
| signature_alt =
| signature_alt =
| website = {{Plainlist|
| website = {{Plainlist|
* {{URL|http://blogs.bbsrc.ac.uk}}
* {{URL|http://benevolent.ai/blog/}}
* {{URL|https://twitter.com/JHunterBBSRC}}}}
* {{URL|https://twitter.com/benevolent_bio}}}}
| footnotes =
| footnotes =
| spouse =
| spouse =
| children =
| children =
}}'''(Ann) Jacqueline Hunter''' [[PhD]]<ref name="hunterphd"/> [[Order of the British Empire|CBE]] [[Academy of Medical Sciences, United Kingdom|FMedSci]] is Professor at [[St George's, University of London|St George's Hospital Medical School]] and [[Chief executive officer|CEO]] of the [[Biotechnology and Biological Sciences Research Council]].<ref name="bbsrceobio">{{cite web |url=http://www.bbsrc.ac.uk/organisation/structures/executive/chief-executive.aspx |title=Chief Executive's biography: Professor Jackie Hunter |archivedate=2013-11-08|archiveurl=http://www.webcitation.org/6KyT40A1P}}</ref><ref name="thes">[http://www.timeshighereducation.co.uk/news/jackie-hunter-to-be-next-bbsrc-chief/2004330.article Jackie Hunter to be next BBSRC chief, Times Higher Education, 2013-06-04]</ref><ref name="twitter">{{twitter|JHunterBBSRC}}</ref>
}}'''(Ann) Jacqueline Hunter''' [[PhD]][[Jackie Hunter#cite note-hunterphd-5|<sup>[5]</sup>]] Hon DSc [[Order of the British Empire|CBE]] [[Academy of Medical Sciences, United Kingdom|FMedSci]] FBPharmacolS FRSB FZL is a board director of [http://www.benevolent.ai BenevolentAI] and the CEO of its bioscience division BenevolentBio where she directs the application of BenevolentAI’s technology for drug development. Jackie Hunter is also a Professor at [[St George's, University of London|St George's Hospital Medical School]] and was [[Chief executive officer|CEO]] of the [[Biotechnology and Biological Sciences Research Council]] (BBSRC)[[Jackie Hunter#cite note-bbsrceobio-4|<sup>[4]</sup>]][[Jackie Hunter#cite note-thes-7|<sup>[7]</sup>]][[Jackie Hunter#cite note-twitter-8|<sup>[8]</sup>]] until March 2016.


==Education==
==Education==
Jackie Hunter was educated at Selwyn School, Matson, Gloucestershire and [[King's School, Gloucester|Kings School, Gloucester]]. She achieved a [[Bachelor of Science|BSc]] in [[Physiology]] and [[Psychology]] at [[Bedford College, London|Bedford College, University of London]] in 1977 and whilst there represented the College on the TV programme University Challenge in 1976. She was awarded her [[Doctor of Philosophy|PhD]] for work carried out at [[London Zoo]] entitled ‘Olfaction, aggression and sexual behaviour of the owl monkey, ''Aotus trivirgatus'',’ in 1981.
Hunter was educated at Kings School<ref name="linkedin">{{cite web |url=http://www.linkedin.com/in/drjackiehunter|title=Jackie Hunter PhD CBE FBPharmacolS LinkedIn profile |archivedate=2013-11-08|archiveurl=http://www.webcitation.org/6KyV2DfmJ}}</ref> and completed her [[Bachelor of Science]] degree and [[PhD]]<ref name="hunterphd">{{cite thesis |degree=PhD |first=A. Jackie|last=Hunter |title=Chemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) |publisher=Bedford College, London |date=1981 |url=http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.258402|authorlink=Jackie Hunter}}</ref> in [[Psychology]] at [[Bedford College (London)|Bedford College, London]] which is now part of [[Royal Holloway, University of London]]. Her PhD thesis was on the psychology of [[Night monkey|owl monkeys (genus Aotus)]].<ref name="hunterphd"/>


==Career==
==Career==
Following her PhD, Hunter undertook a [[Wellcome Trust]] [[Postdoctoral research]] fellowship at St George’s Hospital Medical School before joining the [[pharmaceutical industry]] where she worked for 25 years for [[GlaxoSmithKline|GSK]], Proximagen and OI Pharma Partners.<ref name="oip">{{cite web |url=http://www.oipharmapartners.com |title=OI Pharma Partners - Open Innovation in Healthcare |archivedate=2013-11-08|archiveurl=http://www.webcitation.org/6KyTh7MwS}}</ref><ref name="bbsrceobio"/><ref name="challenges">{{Cite journal | last1 = Hunter | first1 = J.| authorlink = Jackie Hunter| title = Challenges for pharmaceutical industry: New partnerships for sustainable human health | doi = 10.1098/rsta.2010.0377 | journal = Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences | volume = 369 | issue = 1942 | pages = 1817–1825 | year = 2011 | pmid = | pmc = |bibcode = 2011RSPTA.369.1817H }}</ref><ref name="orexin">{{Cite journal
Following her PhD, Jackie Hunter undertook a [[Wellcome Trust]] [[Postdoctoral research]] fellowship at [[St. George's Hospital Medical School RFC|St George’s Hospital Medical School]] before joining the [[pharmaceutical industry]]. She worked at [[Glaxo Laboratories]] first in Greenford and then Ware on novel therapeutics for [[Alzheimer's disease|Alzheimer’s diseases]]. In 1986 she moved to Astra and then subsequently in 1989 to SmithKline and French just prior to the merger that created SmithKlineBeecham (SB). At SB she held a number of management positions and was responsible for delivering a number of candidate molecules to development as well as large scale external collaborations such as the ENU mutagenesis project with the MRC at Harwell. After the merger between SB and GlaxoWellcome to create [[GlaxoSmithKline]] (GSK), she became head of the Neurology and GI Centre of Excellence for Drug Discovery and Site Head at the GSK site in Harlow, Essex.

| doi = 10.1073/pnas.96.19.10911
In 2008 she took up a new role developing GSK’s external innovation strategy and was responsible for developing the concept of the Stevenage Bioscience Catalyst and obtaining funding from government and other bodies to underpin delivery of the project.
| last1 = Hagan | first1 = J. J.

| last2 = Leslie | first2 = R. A.
In 2010 she left [[GlaxoSmithKline|GSK]] to establish an open innovation company – [https://www.linkedin.com/company/oi-pharma-partners-ltd-formerly-pharmivation-ltd- OIPharmapartners Ltd] which was established as a consultancy for the promotion of open innovation in the life sciences, working with governments, academic organisations and companies to formulate open innovation strategies and best practice.
| last3 = Patel | first3 = S.

| last4 = Evans | first4 = M. L.
In 2013 she was appointed Chief Executive of the [[Biotechnology and Biological Sciences Research Council|BBSRC]]. She has also been a non-executive director of [[Proximagen]] group plc (2010-2012) and [https://www.chiltern.com/ Chiltern International Group] (2016- present). She is also a on the Governing Council of [[University of Hertfordshire|Hertfordshire University]].
| last5 = Wattam | first5 = T. A.
| last6 = Holmes | first6 = S.
| last7 = Benham | first7 = C. D.
| last8 = Taylor | first8 = S. G.
| last9 = Routledge | first9 = C.
| last10 = Hemmati | first10 = P.
| last11 = Munton | first11 = R. P.
| last12 = Ashmeade | first12 = T. E.
| last13 = Shah | first13 = A. S.
| last14 = Hatcher | first14 = J. P.
| last15 = Hatcher | first15 = P. D.
| last16 = Jones | first16 = D. N.
| last17 = Smith | first17 = M. I.
| last18 = Piper | first18 = D. C.
| last19 = Hunter | first19 = A. J.
| last20 = Porter | first20 = R. A.
| last21 = Upton | first21 = N.
| title = Orexin a activates locus coeruleus cell firing and increases arousal in the rat
| journal = Proceedings of the National Academy of Sciences of the United States of America
| volume = 96
| issue = 19
| pages = 10911–10916
| year = 1999
| pmid = 10485925
| pmc = 17982
}}</ref><ref>{{Cite journal
| doi = 10.1007/s003359900551
| last1 = Rogers | first1 = D. C.
| last2 = Fisher | first2 = E. M.
| last3 = Brown | first3 = S. D.
| last4 = Peters | first4 = J.
| last5 = Hunter | first5 = A. J.
| authorlink5 = Jackie Hunter
| last6 = Martin | first6 = J. E.
| title = Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment
| journal = Mammalian genome : official journal of the International Mammalian Genome Society
| volume = 8
| issue = 10
| pages = 711–713
| year = 1997
| pmid = 9321461
}}</ref><ref>{{Cite journal
| doi = 10.1046/j.1460-9568.2000.00919.x
| last1 = Piper | first1 = D. C.
| last2 = Upton | first2 = N.
| last3 = Smith | first3 = M. I.
| last4 = Hunter | first4 = A. J.
| title = The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats
| journal = The European Journal of Neuroscience
| volume = 12
| issue = 2
| pages = 726–730
| year = 2000
| pmid = 10712652
}}</ref><ref>{{Cite journal | last1 = Brown | first1 = S. D. M. | last2 = Peters | first2 = P. M. | last3 = Strivens | first3 = J. | last4 = Rogers | first4 = M. | last5 = Hagan | first5 = D. | last6 = Spurr | first6 = J. | last7 = Gray | first7 = N. | last8 = Vizor | first8 = I. C. | last9 = Brooker | first9 = L. | last10 = Whitehill | first10 = D. | last11 = Washbourne | first11 = E. | last12 = Hough | first12 = R. | last13 = Greenaway | first13 = T. | last14 = Hewitt | first14 = S. | last15 = Liu | first15 = M. | last16 = McCormack | first16 = X. | last17 = Pickford | first17 = S. | last18 = Selley | first18 = K. | last19 = Wells | first19 = R. | last20 = Tymowska-Lalanne | first20 = C. | last21 = Roby | first21 = Z. | last22 = Glenister | first22 = P. | last23 = Thornton | first23 = P. | last24 = Thaung | first24 = C. | last25 = Stevenson | first25 = C. | last26 = Arkell | first26 = J. A. | last27 = Mburu | journal = Nature Genetics | first30 = A. | last30 = Erven | volume = 25 | title = A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse | pages = 440–443 | issue = 4 | first29 = R. | last28 = Hardisty | first27 = R. | year = 2000 | last29 = Kiernan | doi = 10.1038/78140 | first28 = P. | pmid = 10932191| pmc =
}}</ref><ref>{{Cite journal | last1 = Piper | first1 = D. C. | last2 = Upton | first2 = N. | last3 = Smith | first3 = M. I. | last4 = Hunter | first4 = A. J. | title = The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats | doi = 10.1046/j.1460-9568.2000.00919.x | journal = European Journal of Neuroscience | volume = 12 | issue = 2 | pages = 726–730 | year = 2000 | pmid = 10712652| pmc = }}</ref> She became Chief Executive Officer (CEO) of the BBSRC in 2013.<ref name="thes"/><ref name="bbsrc2">{{cite web |url=http://www.bbsrc.ac.uk/news/people-skills-training/2013/130604-pr-next-chief-executive-announced.aspx |title=Bioscience innovation leader appointed as next BBSRC Chief Executive |archiveurl=http://www.webcitation.org/6KyTtmu49 |archivedate=2013-11-08}}</ref><ref name="govuk">{{cite web |url=http://www.gov.uk/government/news/new-chief-executive-for-the-biotechnology-and-biological-sciences-research-council |title=Press release: New chief executive for the Biotechnology and Biological Sciences Research Council |archivedate=2013-11-08|archiveurl=http://www.webcitation.org/6KyShD3B8}}</ref>


==Awards==
==Awards==
2005 - Honoured by the Academia del Brutium, Rome, for Contributions to Neuroscience
Hunter was awarded the [[Order of the British Empire|CBE]] for services to the pharmaceutical industry in the [[2010 Birthday Honours]]. She is also a Fellow of the [[British Pharmacological Society]] and was elected a [[Academy of Medical Sciences, United Kingdom|Fellow of the Academy of Medical Sciences (FMedSci)]] in 2014.<ref name="fmedsci">http://www.acmedsci.ac.uk/fellows/fellowship-news/new-fellows/</ref>

2010 - A winner of the [https://www.wisecampaign.org.uk/ 2010 Women of Achievement in Science, Engineering and Technology (SET)] awards in the category SET Discovery, Innovation and Entrepreneurship

2010 - Awarded [[Order of the British Empire|CBE]] in Queen’s Birthday Honours list for Services to the Pharmaceutical Industry

2012 - Awarded Fellowship of the [[British Pharmacological Society]] (BPS)

2014 - Awarded Fellowship of the [[Academy of Medical Sciences, United Kingdom|Academy of Medical Sciences]] (FMedSci)

2014 - Named as one of 50 Movers and Shakers in Bio-Business 2014

2015 - Awarded Fellowship of [[Zoological Society of London]]

2015 - Awarded British Pharmacological Society Astra Zeneca prize for Women in Pharmacology

2016 - Awarded Honorary [[Doctor of Sciences|DSc]] ([[Brunel University London|Brunel University]])

2016 - Awarded Fellowship [[Royal Society of Biology]]


==References==
==References==

Revision as of 13:23, 20 December 2016

Professor Jackie Hunter
Born
Ann Jacqueline Hunter[4]

1956 (age 67–68)[3]
Alma materBedford College, London
Known for
Awards
Scientific career
Institutions
ThesisChemical communication, aggression and sexual behaviour in the owl monkey (Aotus trivirgatus griseimembra) (1981)
Website

(Ann) Jacqueline Hunter PhD[5] Hon DSc CBE FMedSci FBPharmacolS FRSB FZL is a board director of BenevolentAI and the CEO of its bioscience division BenevolentBio where she directs the application of BenevolentAI’s technology for drug development. Jackie Hunter is also a Professor at St George's Hospital Medical School and was CEO of the Biotechnology and Biological Sciences Research Council (BBSRC)[4][7][8] until March 2016.

Education

Jackie Hunter was educated at Selwyn School, Matson, Gloucestershire and Kings School, Gloucester. She achieved a BSc in Physiology and Psychology at Bedford College, University of London in 1977 and whilst there represented the College on the TV programme University Challenge in 1976. She was awarded her PhD for work carried out at London Zoo entitled ‘Olfaction, aggression and sexual behaviour of the owl monkey, Aotus trivirgatus,’ in 1981.

Career

Following her PhD, Jackie Hunter undertook a Wellcome Trust Postdoctoral research fellowship at St George’s Hospital Medical School before joining the pharmaceutical industry. She worked at Glaxo Laboratories first in Greenford and then Ware on novel therapeutics for Alzheimer’s diseases. In 1986 she moved to Astra and then subsequently in 1989 to SmithKline and French just prior to the merger that created SmithKlineBeecham (SB). At SB she held a number of management positions and was responsible for delivering a number of candidate molecules to development as well as large scale external collaborations such as the ENU mutagenesis project with the MRC at Harwell. After the merger between SB and GlaxoWellcome to create GlaxoSmithKline (GSK), she became head of the Neurology and GI Centre of Excellence for Drug Discovery and Site Head at the GSK site in Harlow, Essex.

In 2008 she took up a new role developing GSK’s external innovation strategy and was responsible for developing the concept of the Stevenage Bioscience Catalyst and obtaining funding from government and other bodies to underpin delivery of the project.

In 2010 she left GSK to establish an open innovation company – OIPharmapartners Ltd which was established as a consultancy for the promotion of open innovation in the life sciences, working with governments, academic organisations and companies to formulate open innovation strategies and best practice.

In 2013 she was appointed Chief Executive of the BBSRC. She has also been a non-executive director of Proximagen group plc (2010-2012) and Chiltern International Group (2016- present). She is also a on the Governing Council of Hertfordshire University.

Awards

2005 - Honoured by the Academia del Brutium, Rome, for Contributions to Neuroscience

2010 - A winner of the 2010 Women of Achievement in Science, Engineering and Technology (SET) awards in the category SET Discovery, Innovation and Entrepreneurship

2010 - Awarded CBE in Queen’s Birthday Honours list for Services to the Pharmaceutical Industry

2012 - Awarded Fellowship of the British Pharmacological Society (BPS)

2014 - Awarded Fellowship of the Academy of Medical Sciences (FMedSci)

2014 - Named as one of 50 Movers and Shakers in Bio-Business 2014

2015 - Awarded Fellowship of Zoological Society of London

2015 - Awarded British Pharmacological Society Astra Zeneca prize for Women in Pharmacology

2016 - Awarded Honorary DSc (Brunel University)

2016 - Awarded Fellowship Royal Society of Biology

References

  1. ^ Cite error: The named reference hunterphd was invoked but never defined (see the help page).
  2. ^ Cite error: The named reference fmedsci was invoked but never defined (see the help page).
  3. ^ a b c "Royal Holloway, University of London Dr Jackie Hunter CBE (1956-)". Archived from the original on 2013-11-11.
  4. ^ Jackie Hunter's publications indexed by the Scopus bibliographic database. (subscription required)
  5. ^ Cite error: The named reference oip was invoked but never defined (see the help page).
  6. ^ Cite error: The named reference bbsrceobio was invoked but never defined (see the help page).
Government offices
Preceded by CEO of the Biotechnology and Biological Sciences Research Council
2013–present 		Incumbent
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jackie_Hunter&oldid=755837105"